International Neonatal Immunotherapy Study (INIS).

Slides:



Advertisements
Similar presentations
International Neonatal Immunotherapy Study (INIS).
Advertisements

Richard A. Polin and the COMMITTEE ON FETUS AND NEWBORN Pediatrics 2012;129;1006; originally published online April 30, 2012 Management of Neonates With.
 may be efective in preventing SGA birth in women at high risk of preeclampsia although the effect size is small. (c)
Infection & Preterm Birth. Objectives Understand magnitude of problem of PTB. Gain understanding of role of infection in spontaneous PTB. Overview of.
International Neonatal Immunotherapy Study (INIS).
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Glove Use to Prevent Infections in Preterm Infants Kaufman DA, Blackman A, Conaway.
The premature newborn infant
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Surgery and Neurodevelopmental Outcome of VLBW Infants Morriss FH Jr, Saha S, Bell.
Health during Infancy & Childhood. CHILD HEALTH NURSING: Pediatric nursing also focuses on the healthy growth and development of a child not only at a.
Routine data and opportunities to improve patient outcomes Iain Chalmers Coordinator, James Lind Initiative National Institute of Health Research National.
UOG Journal Club: September 2012 Perinatal outcome in women treated with progesterone for the prevention of preterm birth: a meta-analysis Sotiriadis A,
Chapter 15 Newborn (Perinatal) Guidelines ( )
The impact of managed clinical networks on place of birth and newborn transfers Chris Gale On behalf of the Neonatal Data Analysis Unit and the Medicines.
Progesterone Therapy for Preterm Labor Perinatal Conference April 14, 2006.
Premature Infant Outcomes Linda Wallen, MD. Prevalence of Cerebral Palsy VLBW Infants MortalityCerebral Palsy (% live births)(% survivors)
Rituximab (RITUXAN) & Multiple Sclerosis
Original Article B-Cell Depletion with Rituximab in Relapsing- Remitting Multiple Sclerosis Stephen L. Hauser, M.D., Emmanuelle Waubant, M.D., Ph.D., Douglas.
To treat or not to treat? Infants born with maternal chorioamnionitis Mary Angela Woodward,MD April 29,2015.
Neonatal Group B Streptococcal Infections
THERAPEUTIC HYPOTHERMIA Heike Geduld August 2007.
報 告 者 王瓊琦. postpartum depression : identification of women at risk.
Nov 2007 ACoRN © Infection Sequence. Nov 2007ACoRN ©
Fetal Origins of Disease Hypothesis Grace M. Egeland, Ph.D. University of Bergen.
Early Nutritional Support Influences Body Composition at Four Months Corrected Age in Very Low Birth Weight Preterm Infants Ellen C Christiansen, MD 1,
Sarah Struthers, MD March 19, 2015
Follow-up at two years INIS International Neonatal Immunotherapy Study.
Perinatal CDC Prevention Guidelines Priscilla Joe, MD.
Arch Neurol. 2009;66(8): Published online June 8, 2009 (doi: /archneurol ).
The ORACLE Children Study Sara Kenyon University of Leicester Peter Brocklehurst University of Oxford Neil Marlow University College London David Taylor.
Oxygen therapy for the premature infant Retinopathy of prematurity (ROP) Teaching Evidence-based Practise 15 th September 2015 Kenneth Tan Monash Newborn.
Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants Intravenous immunoglobulin for suspected or subsequently.
International Neonatal Immunotherapy Study National Perinatal Epidemiology Unit Oxford
Outcomes of preterm birth Stefan Johansson Department of Neonatology, Karolinska university hospital Department of Medical Epidemiology and Biostatistics,
Evidence Based Medication Use in the NICU: Erythropoietin Dan Ellsbury MD Director, Continuous Quality Improvement Pediatrix Medical Group.
Procalcitonin. Objectives Review current data on procalcitonin Review its use at UCI MC.
INIS in practice. Recruitment Ideas for boosting recruitment in your unit Raising awareness of INIS on your unit Dealing with staff antagonism Coordinating.
Retinopathy of Prematurity: A Neglected Public Health Issue Krishnendu Sarkar Professor Regional Institute of Ophthalmology Kolkata.
Controversies in managing neonatal infections David Isaacs Children’s Hospital at Westmead Sydney Australia.
Introduction More than 2 out of 3 adults and one third of children between 6 – 19 years of age are obese or overweight (1,2). Obese individuals accrued.
International Neonatal Immunotherapy Study. Co-ordinating Centre National Perinatal Epidemiology Unit Oxford
A CONSENT DVD/ VIDEO DESIGNED TO IMPROVE CONSENT UPTAKE TO RANDOMISED CONTROLLED TRIALS IN NEONATOLOGY: A PILOT STUDY IN THE INIS NETWORK [VINIS] Priya.
Changing Prevalence of Cerebral Palsy Coleen Boyle, Ph.D. National Center on Birth Defects and Developmental Disabilities Centers for Disease Control and.
INIS Collaborators’s Meeting PSANZ 4 April Total 117 centres Total 2272 babies Well done, thank you for your hard work!  Because the event rate.
SCH Journal Club Use of time from fever onset improves the diagnostic accuracy of C-reactive protein in identifying bacterial infections Wednesday 13 th.
PVL_COUNTRY_DATE00/1 Département santé et recherche génésiquesDepartment of reproductive health and research Day 3 - Session 2 DAY (3) Session 2 Presentation:
NICU Educators. Early onset neonatal infections Within the first 72 hours of life Manifest – pneumonia and/or septicaemia Incidence = in gender High mortality.
Effects of Gut Bacteria on Infants By Adrienne Bacon.
Focus on health and care of mothers and infants ChiMat conference, 2009 Professor Mary Renfrew Mother and Infant Research Unit.
507 Bacterial pathogenesis
Causes of neonatal mortality Lawn JE, et al. Intl J Epidemiol (2006)
LSU Journal Club Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia A Systematic Review and Meta-analysis Scott Hebert,
Probiotics- 2 year experience Anitha James Royal Gwent hospital.
Hypoxic-Ischaemic Encephalopathy (HIE) in Wales R Adappa.
Barbara Schmidt, Kristine Sandberg Knisely Chair in Neonatology
Therapeutic Hypothermia in Neonatal Hypoxic-Ischaemic Encephalopathy An audit of clinical management and follow up Malini Ketty, Nitin Goel, Sujoy Banerjee.
M. Boyle1,3,4, R. Pinnamaneni 2,3,4, F. Malone 2,4, J
Infection & Preterm Birth
Is Patent Ductus Arteriosus Ligation Responsible for Adverse Outcome in Very Low Birth Weight (VLBW) Infants?  MJ. Qureshi, MD1*, M. Bamehrez, MD1, F.
THE UNIVERSITY of TENNESSEE HEALTH SCIENCE CENTER
The Duration of Hypotension Prior to Initiation of Effective Antimicrobial Therapy is the Critical Determinant of Survival in Human Septic Shock Anand.
2 Birmingham Children’s Hospital, Birmingham
Correlation of developmental outcome with severity of bronchopulmonary dysplasia in extremely low gestational age neonates Karen Belen, Chengqiu Lu, Narges.
Outcomes of Extremely Preterm Infants
Breastfeeding for six months is an independent association of language and cognitive intelligence in infants at 18 months. Sonia Kua1, Julie Qunilivan1,2,3.
THE UNIVERSITY of TENNESSEE HEALTH SCIENCE CENTER
Pediatric consequences of Assisted Reproductive Technologies
Chen S, Dong Y, Kiuchi MG, et al
The Ethics of Data Sharing in the Antenatal Corticosteroids Trial
Corticosteroids in the ICU
Newborn Services, Women’s Health & Child Development Unit
Presentation transcript:

International Neonatal Immunotherapy Study (INIS)

Why is the INIS follow up study so important? William Tarnow-Mordi Westmead Hospital and Children’s Hospital at Westmead NHMRC Clinical Trials Centre University of Sydney

because INIS will 1.exemplify disability-free survival as a primary outcome measure in neonatal trials. 2.test common preconceptions on the importance of various pathogens and clinical presentations in neonatal sepsis. 3.Provide evidence on potential immuno-modulatory effects of IVIG 4.be the first large-scale use of a Parent Report of cognitive performance at 2 years, validated against the BSID II MDI. 5.aim for as high as possible follow up to maximise validity.

William Silverman (‘Fumer’) Taught his students and friends to consider the long term consequences of neonatal care, for patients and families to cultivate a habit of lifelong (un) learning ‘semper plangere’ (always complain) - and look for better evidence

1 Disability-free survival as a primary outcome measure

IVIG for suspected infection in neonates Ohlsson Lacy, Cochrane Library 2005; controls No IVIG treated IVIG Odds ratio MORTALITY24% 38/ % 23/ (0.42– 1.00) DISABILITY ???

History of oxygen use in preterm neonates early 1950s: unrestricted, high O 2, subsequent huge increase in RLF (severe ROP) From: Wright K. Textbook of Ophthalmology Eds. Williams & Wilkins. Chapter 22

Cost of preventing Retrolental Fibroplasia? Cross K. Lancet 1973 Each baby whose sight was saved by limiting oxygen may have cost –16 hypoxic deaths and –many survivors with spastic diplegia A large RCT should have evaluated not just ROP but mortality and long term morbidity

Early postnatal (<96 hr) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Review : Halliday, Ehrenkrantz, Doyle. 7 RCTs with 991 infants 69% increase in relative risk of cerebral palsy [1.69 (1.2 – 2.38)] Re-illustrates risk of introducing an effective therapy (known to reduce chronic lung disease) without knowing its impact on disability-free survival

2 Relative importance of specific pathogens and presentations

Two personal (un) learning points

(a) IVIG is not indicated in coagulase negative staphylococcus (CONS) sepsis because it has no impact on long term morbidity …

(b) IVIG is not indicated in Culture-negative clinical infection (clinical sepsis treated with antibiotics for 5 days or more, with no pathogen identified) because it is not associated with adverse long term outcome …

Association between cerebral palsy and coagulase-negative staphylococci. Mittendorf et al. Lancet 1999 Cultured the space between the membranes after aseptic separation of amnion from chorion in 107 preterm infants in MagNET trial 35% grew no organisms. 28% grew CONS CONS isolated in 4/5 (80%) infants who later manifest CP vs 26/102 (25%) who did not. (p<0.02) Remained significant after adjusting for birthweight, seizures, neonatal ventilation and presentation.

Mittendorf et al. Lancet 1999 First report of a specific perinatal bacterium in association with CP. Generates the hypotheses that –CONS may play a causal role in CP –mediated by virulence factors such as haemolysins, deoxyribonuclease, slime and adhesins

Cerebral Palsy after neonatal sepsis Murphy et al, BMJ 1997 Population-based case control study in year olds born before 32 weeks gestation After adjusting for gestation, antenatal and intrapartum risk factors, odds ratio for CP after neonatal sepsis was 3.6 (2.5 – 9.3) CONS was the single most common cause of neonatal sepsis in this cohort (25-50% of all pathogens) David Isaacs, unpublished data

Stoll et al JAMA 2004 Neurodevelopmental and growth impairment among ELBW infants with neonatal infection 6093 infants < 1000 g bwt assessed at 18 – 22 months corrected for gestation

Neuro-developmental Impairment (NDI) in infected versus uninfected infants CategoryN (%) NDI (unadjusted) OR for NDI adjusted for 21 risk factors uninfected2161 (35) 29%- Culture neg clinical infection 1538 (25) 43%1.3 ( ) Culture positive sepsis 1922 (32) 48%1.5 (1.2 – 1.7) Sepsis and NEC 279 (5) 53%1.8 (1.4 – 2.5) meningitis193 (3) 48%1.6 (1.1 – 2.3)

Neuro-developmental impairment in infants with different pathogens versus uninfected infants CategoryN % NDI (unadjusted) Adjusted OR for NDI relative to uninfected uninfected %- CONS853 44%1.3 (1.1 – 1.6) Other Gm pos %1.7 (1.2 – 2.3) Gram negative %1.8 (1.2 – 7.6) Fungal96 57%1.4 (0.9 – 2.2)

After adjustment for antenatal, perinatal and postnatal factors Neonatal infection was associated with OFC < 10 th centile at 36 weeks Neonatal infection, including CONS and culture-negative sepis, was associated with increased neuro-developmental impairment and poor head growth at months

The Stoll cohort study raises important questions Is neonatal infection a cause of long term neuro-developmental impairment? Is Coagulase negative staphylococcus the most common infective cause of NDI? Can anti-inflammatory therapies, like IVIG, reduce, increase or leave disability unchanged after neonatal infection?

Limitations of an observational study in birthweight defined cohort The uninfected group had more SGA babies (24%) than the other groups (14%, 14%, 13%, 16%) (p < 0.01) Do SGA babies fare better (less infection, less NDI) than AGA babies of similar weight, even after adjustment for gestation? Could this be a competing explanation for the association between infection and NDI?

Given the totality of evidence linking neonatal and perinatal sepsis with NDI (including gestation-based studies), whether neonatal infection contributes to NDI remains a major, unanswered question RCTs like INIS are the only way to resolve the uncertainty reliably. If IVIG reduces NDI and/ or disability this would be good evidence that neonatal infection is causative.

3 Potential immuno-modulatory effects of IVIG

Pro inflammatory properties of IVIG Promoting opsonic activity, fixation of complement, antibody dependent cytotoxicity, neutrophil chemiluminescence, phagocytosis and release of stored neutrophils.

Anti-inflammatory properties of IVIG Down-regulation of inflammatory cytokines via Fc receptor blockade, provision of anti-idiotype antibodies interference with activation of T-cells, B-cells, the cytokine network and complement Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. Kazatchkine MD,. et al. N Engl J Med 2001

Immunomodulatory effects of IVIG in cerebral inflammatory and auto-immune conditions Systematic Reviews of RCTs support use of IVIG in Chronic Inflammatory De-myelinating Polyneuropathy (CDIP) Guillain-Barre syndrome Idiopathic Thrombocytopenia Kawasaki disease Multiple Sclerosis

In Kawasaki disease, although we do not fully understand the mechanism of immune damage following infection, RCTs have shown that IVIG is an important anti- inflammatory therapy. It is now a standard of care. INIS provides an opportunity to demonstrate whether IVIG is effective in neonatal sepsis. If so, it will stimulate more intensive research into mechanisms.

91 patients within 6 weeks of the first event suggestive of multiple sclerosis Randomly assigned to 2 g/ kg IVIG or placebo Then 0.4 g/ kg every 6 weeks for a year

IVIG more than halved the risk of developing definite MS within one year –Relative risk 0.36 (0.15 – 0.88) –Fewer and smaller cerebral lesions on MRI

Duggan et al, Lancet % of babies born before 30 weeks gestation had MRI cerebral lesions on scans done at a median 2 days after birth The risk of cerebral lesions increased after –raised maternal CRP –preterm rupture of membranes Could postnatal IVIG benefit pre-existing cerebral inflammation (as in adult MS)?

Does intravenous immunoglobulin (IVIG) reduce the primary outcome of mortality or major disability at two years corrected for gestation in babies receiving antimicrobial therapy for a suspected or proven serious infection? * includes anti-virals or anti-fungals as appropriate Primary Research Question

Selected subgroup analyses

Clinical severity at presentation from data recorded at trial entry High severity –Looks seriously ill or inactive AND has low or high temperature, or prolonged capillary return, or is ventilated, or FiO2/ SpO2 consistent with high mortality risk Moderate severity –None of the above, but WCC 15 mg/L, or platelets < 50 x 10 9 /L, or pathogens in blood or sterile site, or pneumonia, or CSF suggests bacterial meningitis Low severity –None of the above

Maternal chorioamnionitis infants born at < 30 weeks gestation to women with clinical chorioamnionitis vs infants born at < 30 weeks gestation with no clinical chorioamnionitis vs infants born at = 30 weeks.

Elevated maternal CRP infants born at 80mg/l) vs infants born at 30 weeks

Preterm birth and duration of membrane rupture Born at 48 hours vs born at > 37 weeks.

Early onset infection (non contaminant organisms isolated from culture sent before 48 hours) a) group B streptococcal disease b) other pathogens c) indeterminate aetiology

Late onset infection (non contaminant organisms isolated from culture sent after 48 hours) a) gram positive organisms except Staphylococcus epidermidis b) staphylococcus epidermidis c) other pathogens d) clinical sepsis with no organism grown

Parent Report of cognitive performance at 2 years

Validation of a parent report measure of cognitive development in very preterm infants Johnson et al. Dev Med Child Neurol two year olds who were < 30 weeks gestation in UK follow up centres Assessed with the Mental Development Index of the Bayley II Scales and the modified Parent Report questionnaire Parent report score < 49 predicted MDI < 70 with 81% sensitivity and 81% specifity

Parent report will be used to assess cognitive outcome at 2 years corrected in all patients Alongside paediatrician assessment of general health and neurological status Bayley II scales will be performed in 600 ANZ infants, to validate Parent Report in ANZ

5 INIS aims for a follow up rate as high as possible

Take home messages In the light of current evidence, collaborators are encouraged to recruit eligible infants still being treated with antibiotics for suspected or proven clinical sepsis and –CONS –Clinical chorioamnionitis (if still on antibiotics) –Elevated maternal CRP (if still on antibiotics) –Culture-negative clinical sepsis/ pneumonia if antibiotics are planned, or have been given, for 5 or more days NB it’s prudent not to recruit infants who will be impossible to follow up at 2 years